Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Net Cash Flow: 2023-2024

Historic Net Cash Flow for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $262.7 million.

  • Zenas BioPharma's Net Cash Flow fell 59.39% to $71.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$244.4 million, marking a year-over-year decrease of 184.93%. This contributed to the annual value of $262.7 million for FY2024, which is 2619.00% up from last year.
  • Zenas BioPharma's Net Cash Flow amounted to $262.7 million in FY2024, which was up 2,619.00% from -$10.4 million recorded in FY2023.
  • Zenas BioPharma's 5-year Net Cash Flow high stood at $262.7 million for FY2024, and its period low was -$10.4 million during FY2023.
  • Over the past 2 years, Zenas BioPharma's median Net Cash Flow value was $126.2 million (recorded in 2023), while the average stood at $126.2 million.
  • Data for Zenas BioPharma's Net Cash Flow shows a peak YoY surged of 2,619.00% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's Net Cash Flow (Yearly) stood at -$10.4 million in 2023, then soared by 2,619.00% to $262.7 million in 2024.